Purpose To quantify the prognostic effect of the location of prostate cancer (PCa) metastases
on cancer-specific mortality (CSM) and the rate of other-cause mortality (OCM) in …

Background Limited data exist on the impact of the site of metastases on survival in patients
with stage IV prostate cancer (PCa). Objective To investigate the role of metastatic …

Objective To determine the prognostic relevance of non‐regional lymph node (NRLN)
metastases presenting synchronously with bone metastases in metastatic prostate cancer …

Introduction Metastatic prostate cancer (MPC) prognosis is variable. Few population-based
studies have examined the impact of particular visceral metastatic sites on MPC survival …

Prostate cancer (PCa) survival markedly decreases with the occurrence of distant
metastasis, and treatment decisions can be influenced by metastasis site, and affect patient …

Introduction It is unknown whether specific locations of visceral metastatic sites affect overall
survival (OS) of metastatic prostate cancer (mPCa) patients. We tested the association …

BACKGROUND Distant metastasis, particularly visceral metastasis (VM), represents an
important negative prognostic factor for prostate cancer (PCa) patients. However, due to the …

BACKGROUND There is few data on what constitutes the distribution of metastatic sites in
prostate cancer (PCa). The aim of our study was to systematically describe the most …

Objectives To evaluate the prognostic importance of concomitant non‐regional lymph node
(NRLN) and bone metastases in men with synchronous metastatic hormone‐sensitive …

Background The present of metastases is a poor prognostic factor in prostate cancer, but the
prognostic impact of different distant metastases pattern is unclear. The aim of this study is to …